Richard Lin

41PUBLICATIONS
149CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHybrid and electric vehicles and powertrains
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jun 15, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.

|Nov 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.

Magdalena Corona, Samantha Brown, Kai Rejeski

|Aug 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.

Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin

|Jul 02, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan

|Jun 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant.

Susan DeWolf, Jason Kuttiyara, Paola Vinci

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

Pageof 7

Frequent Collaborators

18 joint publications

Miguel-Angel Perales

14 joint publications

Parastoo Dahi

12 joint publications

Roni Shouval

12 joint publications

Sergio Giralt